Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × abrysvo × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 26 fludarabine 18 Rituximab 13 obinutuzumab 10 Bendamustine Hydrochloride 9 venetoclax 7 Lenalidomide 7 pembrolizumab 5 Prednisone 5 Exercise 5 zanubrutinib 4 fludarabine phosphate 4 Mesna 4 Etoposide 4 Doxorubicin 4 Cytarabine 4 Blood Specimen Collection 4 Biopsy 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 Vincristine 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Radiotherapy 3 Palliative Care 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡